2018 annual financial data

Immunovant 2018 Financial results

Direct answer

Revenue was Not available.

Operating income was -450 USD and net income was -450 USD.
Operating cash flow was -128,297,000 USD.

Get free Immunovant email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
Not available
Operating income
-450 USD
Net income
-450 USD
Operating cash flow
-128,297,000 USD